Solactive Pharma Breakthrough Value Index
Solactive Pharma Breakthrough Value Index aims to track the performance of a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The index is calculated as a net total return index and denominated in US Dollar.
Master Data
| ISIN: | DE000SLA30N4 |
| Bloomberg Ticker: | SOLBIOT Index |
| WKN: | SLA30N |
Current Quotes
| Last quote (15 Jul 2025): | 374.32 |
| Day range: | 374.27 / 374.67 |
| Change abs./rel.: | 1.08 / 0.29% |
| Year range: | 313.60 / 375.99 |
| Name | Index Shares |
|---|---|
| XERIS BIOPHARMA HOLDINGS INC | 2.364247 |
| IPSEN SA | 0.083837 |
| IONIS PHARMACEUTICALS INC | 0.296492 |
| ASTRAZENECA PLC-SPONS ADR | 0.129347 |
| JOHNSON & JOHNSON | 0.060138 |
| ROYALTY PHARMA PLC- CL A | 0.303678 |
| MITSUBISHI CHEMICAL GROUP | 1.846048 |
| BIOCRYST PHARMACEUTICALS INC | 1.303564 |
| NIPPON SHINYAKU CO LTD | 0.37018 |
| JAZZ PHARMACEUTICALS PLC | 0.072217 |
| TRAVERE THERAPEUTICS INC | 0.554141 |
| PTC THERAPEUTICS INC | 0.190614 |
| INNOCARE PHARMA LTD | 7.991407 |
| HALOZYME THERAPEUTICS INC | 0.164388 |
| UNITED THERAPEUTICS CORP | 0.031732 |
| CATALYST PHARMACEUTICALS INC | 0.456485 |
| ULTRAGENYX PHARMACEUTICAL INC | 0.259565 |
| AMGEN INC | 0.030858 |
| ALNYLAM PHARMACEUTICALS INC | 0.040996 |
| BEONE MEDICINES LTD-ADR | 0.040573 |
| PHARMA MAR SA | 0.095914 |
| GENMAB A/S | 0.041447 |
| PHARMING GROUP NV | 12.166341 |
| ZEVRA THERAPEUTICS INC | 1.237581 |
| LG CHEM LTD | 0.057895 |
| BIOGEN INC | 0.066661 |
| SWEDISH ORPHAN BIOVITRUM AB | 0.342457 |
| BIOMARIN PHARMACEUTICAL INC | 0.138785 |
| BRISTOL-MYERS SQUIBB CO | 0.164092 |
| KYOWA KIRIN CO LTD | 0.665242 |
| LIGAND PHARMACEUTICALS INC | 0.087298 |
| EISAI | 0.349445 |
| VERTEX PHARMACEUTICALS INC | 0.02053 |
| SAREPTA THERAPEUTICS INC | 0.097296 |
| INCYTE CORP | 0.141608 |
| CHUGAI PHARMACEUTICAL CO LTD ORD | 0.212337 |
| NOVARTIS AG-SPONSORED ADR | 0.086739 |